Senti Biosciences, Inc. (SNTI) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-03-11

Senti Biosciences, Inc. (SNTI) — no SEC Form 4 insider filings recorded in the last 90 days. 6 Form 8-K material event filings were reported by SNTI in the last 90 days. InsiderAlpha tracks every SNTI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Senti Biosciences, Inc. (SNTI)

SEC CIK	0001854270

90-Day SEC Filing Activity

Form 8-K filings (90d)	6
Latest Form 4 filing	2026-03-11

Recent SNTI Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-03-09	Rajangam Kanya	Pres. & Chief Med. & Dev. Off.	F — Tax withholding / forfeiture	10.8K	$0.00	—	SEC
2026-03-09	Lu Timothy K	CEO	F — Tax withholding / forfeiture	80.7K	$0.00	—	SEC
2026-02-02	Rajangam Kanya	Pres. & Chief Med. & Dev. Off.	F — Tax withholding / forfeiture	1.4K	$0.00	—	SEC
2026-02-02	Lu Timothy K	CEO	F — Tax withholding / forfeiture	4.2K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Senti Biosciences, Inc. (SNTI). Updated in real time as new filings are submitted to the SEC.

Recent SNTI Form 8-K Material Events

2026-07-15 — Item 1.01, 2.02, 5.01, 7.01, 8.01, 9.01 [SEC]
2026-07-15 — Other · neutral [SEC]
Trading halt (T1) for SNTI. SNTI
2026-05-26 — Item 1.01, 2.03, 9.01 [SEC]
2026-05-14 — Item 2.02, 8.01, 9.01 [SEC]
2026-05-01 — Item 1.01, 2.03, 3.02, 5.01, 9.01 [SEC]

Recent Insider Filings

2026-03-11 — Rajangam Kanya (Pres. & Chief Med. & Dev. Off.)
2026-03-11 — Lu Timothy K (CEO)
2026-02-03 — Rajangam Kanya (Pres. & Chief Med. & Dev. Off.)
2026-02-03 — Lu Timothy K (CEO)
2025-07-18 — Baum Bryan Daniel (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SNTI insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

SNTI Insider Trading — FAQ

What is the latest insider trade for SNTI?: Senti Biosciences, Inc. (SNTI) had 0 insider filings in the last 90 days, with the most recent on 2026-03-11. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying SNTI stock?: 0 insider purchases of SNTI were filed in the last 90 days.
How many insiders are selling SNTI stock?: 0 insider sales of SNTI were filed in the last 90 days.
Where can I see SNTI SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every SNTI SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live SNTI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.